Liesbeth Reneman is a Neuroradiologist at the Academic Medical Center (AMC) at the Univeristy of Amsterdam in Amsterdam, The Netherlands. She obtained her Ph.D. degree cum laude on neuroimaging of the potentially neurotoxic effects of ecstasy in 2001. She was trained as a radiologist from 2001 to 2007 and subsequently did a European fellowship in neuroradiology (2006-2007). Over the past decade, she developed her own initiated ground breaking translational line of research directed toward the effects of psychotropic drugs on the (developing) brain using neuroimaging techniques, MRI in particular. Her current line of research involves the effects of psychotropic drugs on brain development in a large project in which the effects of fluoxetine and methylphenidate on brain development and behavior are investigated in randomized clinical trials (the ePOD project: http://www.epod-study.nl) and animals. Dr. Reneman is the PI of the Drug Research and Brainimaging group at the AMC, in which 12 Ph.D. students and postdocs take part. To set up this line of research at the AMC, personalized funding was obtained in 2007. In addition, she received funding from other competitive funding agencies including an EU FP6 project from ERA-NET PrioMedChild (2010) of which she is the coordinator. In addition, she is the cofounder and managing body of the Brain Imaging Center (BIC) at the AMC (http://www.lebic-amc.nl).
Biography Updated on 29 January 2012